Short answer · Medically reviewed summary · Last updated: 2026-05-08
TL;DR: Leprosy, also known as Hansen’s disease, is a rare infectious condition globally, with approximately 200,000 new cases reported annually according to the World Health Organization. While it is no longer considered a public health epidemic in most countries, underdiagnosis remains a significant challenge, meaning the true prevalence of Leprosy is likely higher than official statistics suggest. What is the global prevalence of Leprosy? The global prevalence of Leprosy has declined significantly over the last several decades due to multidrug therapy (MDT).
What is the prevalence of Leprosy?
Prevalence of Leprosy: how many people are affected worldwide, differences by sex and region, with sources.
TL;DR: Leprosy, also known as Hansen’s disease, is a rare infectious condition globally, with approximately 200,000 new cases reported annually according to the World Health Organization. While it is no longer considered a public health epidemic in most countries, underdiagnosis remains a significant challenge, meaning the true prevalence of Leprosy is likely higher than official statistics suggest.
What is the global prevalence of Leprosy?
The global prevalence of Leprosy has declined significantly over the last several decades due to multidrug therapy (MDT). However, the disease persists, particularly in tropical and subtropical regions. According to the World Health Organization (WHO), over 200,000 new cases are diagnosed each year. Because Leprosy has a long incubation period—often five to twenty years—many individuals remain undiagnosed, making it difficult to determine the exact number of people currently living with the condition.
How does Leprosy affect different populations?
Leprosy affects both males and females, though global surveillance data consistently shows a higher incidence among males. Regarding age, Leprosy can manifest at any stage of life, though it is most frequently diagnosed in adults. Pediatric cases do occur, and their presence in a community is a critical indicator of active transmission. Geographic distribution is highly uneven, with the vast majority of cases clustered in countries like India, Brazil, and Indonesia.
What are the challenges in tracking Leprosy statistics?
Accurate data collection for Leprosy is hindered by several factors that complicate epidemiological modeling:
- Social Stigma: Fear of discrimination often leads patients to delay seeking medical evaluation.
- Diagnostic Complexity: Early symptoms of Leprosy can be subtle and easily misidentified as other dermatological conditions.
- Resource Limitations: In endemic regions, limited access to specialized healthcare infrastructure prevents systematic reporting.
- Community Perspectives: Real-world data from platforms like DiseaseMaps.org provides vital, patient-centered insights that complement formal clinical reporting, highlighting the daily lived experience of those managing Leprosy.
Next steps
- Consult a dermatologist or an infectious disease specialist if you notice persistent, painless skin lesions or numbness.
- Visit the World Health Organization or NIH GARD websites for official regional health guidelines regarding Leprosy.
- Connect with the DiseaseMaps.org community to share experiences and find support from others navigating rare disease journeys.
Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.
References
- World Health Organization (WHO): Leprosy (Hansen's disease) Fact Sheets.
- NIH Genetic and Rare Diseases Information Center (GARD): Hansen's Disease.
- Orphanet: Leprosy (ORPHA:527).
- Centers for Disease Control and Prevention (CDC): Hansen's Disease (Leprosy).
